dinitrochlorobenzene and dacarbazine

dinitrochlorobenzene has been researched along with dacarbazine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	2 (28.57)	18.2507
2000's	3 (42.86)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goodnight, JE; Morton, DL	1
Thiers, BH	1
Hart, AA; Israels, SP; Kroon, BB; Nieweg, OE; Rümke, P; Strobbe, LJ	1
Becker, JC; Bröcker, EB; Kämpgen, E; Schwaaf, A; Trcka, J	1
Becker, JC; Bröcker, EB; Fischer, WH; Lutz, WK; Wack, C	1
Becker, JC; Bröcker, EB; Fischer, WH; Kirst, A; Lutz, WK; Wack, C	1
Becker, JC; Beiteke, U; Bröcker, EB; Durani, B; Jünger, M; Junghans, V; Kortüm, AK; Mauch, C; Remling, R; Schadendorf, D; Schulze, HJ; Terheyden, P	1

Reviews

2 review(s) available for dinitrochlorobenzene and dacarbazine

Article	Year
The role of immunotherapy in the management of patients with malignant melanoma. World journal of surgery, 1979, Jul-30, Volume: 3, Issue:3 Topics: Bacterial Vaccines; BCG Vaccine; Corynebacterium; Dacarbazine; Dinitrochlorobenzene; Drug Therapy, Combination; Humans; Immunotherapy; Melanoma; Skin Neoplasms	1979
Immunotherapy of malignant melanoma. Journal of the American Academy of Dermatology, 1982, Volume: 6, Issue:4 Pt 1 Topics: Antigens, Neoplasm; BCG Vaccine; Cholera Vaccines; Clinical Trials as Topic; Dacarbazine; Dinitrochlorobenzene; Double-Blind Method; Humans; Immunotherapy; Interferons; Levamisole; Melanoma; Random Allocation; Skin Neoplasms; Skin Tests; Transfer Factor	1982

Trials

2 trial(s) available for dinitrochlorobenzene and dacarbazine

Article	Year
Immunotherapy of malignant melanoma. Journal of the American Academy of Dermatology, 1982, Volume: 6, Issue:4 Pt 1 Topics: Antigens, Neoplasm; BCG Vaccine; Cholera Vaccines; Clinical Trials as Topic; Dacarbazine; Dinitrochlorobenzene; Double-Blind Method; Humans; Immunotherapy; Interferons; Levamisole; Melanoma; Random Allocation; Skin Neoplasms; Skin Tests; Transfer Factor	1982
Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma. Melanoma research, 1997, Volume: 7, Issue:6 Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms	1997

Article

Year

Immunotherapy of malignant melanoma.

Journal of the American Academy of Dermatology, 1982, Volume: 6, Issue:4 Pt 1

Topics: Antigens, Neoplasm; BCG Vaccine; Cholera Vaccines; Clinical Trials as Topic; Dacarbazine; Dinitrochlorobenzene; Double-Blind Method; Humans; Immunotherapy; Interferons; Levamisole; Melanoma; Random Allocation; Skin Neoplasms; Skin Tests; Transfer Factor

1982

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.

Melanoma research, 1997, Volume: 7, Issue:6

Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms

1997

Other Studies

4 other study(ies) available for dinitrochlorobenzene and dacarbazine

Article	Year
[Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1998, Volume: 49, Issue:1 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Female; Follow-Up Studies; Humans; Immunotherapy; Infusions, Intravenous; Irritants; Male; Melanoma; Middle Aged; Skin; Skin Neoplasms; Treatment Outcome	1998
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model. Melanoma research, 2001, Volume: 11, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Dose-Response Relationship, Drug; Female; Immunotherapy; Irritants; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Time Factors	2001
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. Cancer immunology, immunotherapy : CII, 2002, Volume: 51, Issue:8 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Dinitrochlorobenzene; Immunotherapy; Irritants; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Ribonucleases; RNA, Messenger; T-Lymphocytes; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. Journal of cancer research and clinical oncology, 2007, Volume: 133, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dinitrochlorobenzene; Disease-Free Survival; Female; Germany; Humans; Irritants; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Analysis	2007